MD, Neurologist, PhD Student in Experimental Medicine - Basic and Clinical Neurosciences, University of L'Aquila 🧠
Joined May 2016
- Tweets53
- Following768
- Followers61
- Likes196
Federico De Santis retweeted
Breakthrough #stroke on oral anticoagulation differs by sex.
Read about how women show worse recovery and more recurrence in the ASPERA cohort. @mattfos89 @luciodanna2 @RaffaeleOrnello @fededs00 @Simona_Sacco_ @univaq @AUSLRomagna ahajrnls.org/4ctWvNX
Federico De Santis retweeted
New in Cephalalgia!
Misdiagnosis is common in migraine—28% were wrongly diagnosed with conditions like sinusitis or cervical issues. Resistant/refractory cases had more testing, but not more misdiagnoses. Timely and accurate diagnosis is needed.
journals.sagepub.com/doi/10.…
#migraine #headache #brain #pain #neurology #neuroscience
@lab_neu2024, @fededs00, @Simona_Sacco, @RaffaeleOrnello
Federico De Santis retweeted
A huge thank you to all coauthors and collaborators worldwide for their expertise, energy, and commitment 🌍💡@Simona_Sacco_
@luciodanna2 @FishingNeurons @ECSandset @SCouttsMD @PoojaKathri @fededs00 @univaq @AUSLRomagna
Federico De Santis retweeted
Open Access:
A cross-sectional study finds #sleep disturbance influences the relationship between #migraine frequency & #glymphatic dysfunction
headachejournal.onlinelibrar…
@RaffaeleOrnello @federicosalfi @fededs00 @alessandraSple2 @Simona_Sacco_
Federico De Santis retweeted
🚨 Just published! 🚨
📄 Real-world outcomes following dual antiplatelet therapy in mild-to-moderate ischemic stroke with anterior versus posterior circulation infarct: a READAPT study propensity matched analysis
journals.sagepub.com/home/TA…
Federico De Santis retweeted
🎉 Congratulations to @fededs00, neurologist and PhD candidate at @univaq, for receiving the @ESOstroke Young Investigator Award! 👏🏻👏🏻👏🏻
A well-deserved recognition!
Kudos to Raffaele Ornello, Matteo Foschi and Eleonora De Matteis, key members of the project team. So proud! 💪🏻🧠
Federico De Santis retweeted
New study! 🚨 @TANeurolDisord
In patients with minor #stroke or TIA, higher admission SBP is linked to⬆️ risks of early deterioration, recurrent vascular events, and 🩸 after #DAPT
@Simona_Sacco_ @fededs00 @luciodanna2 @RaffaeleOrnello @luciodanna2
journals.sagepub.com/home/ta…
Federico De Santis retweeted
🧠 💊 Just published in @ESOstroke Journal: DAPT in patients with minor stroke or TIA and cancer—what's the risk? 🚨
@univaq @Simona_Sacco_ @RaffaeleOrnello @fededs00 @Eleonor32576320 @luciodanna2
journals.sagepub.com/doi/10.…
Federico De Santis retweeted
📢#ASPERA study has been officialy presented at #ISA-stroke congress 2025 by @mattfos89 … ➡️DM us @mattfos89 @RaffaeleOrnello @Simona_Sacco_ @fededs00 to join the study @univaq @ISA_AII_Young
Federico De Santis retweeted
One recurring question I often get during lectures on migraine, stroke, and PFO is about the use of antithrombotic therapy. To address this, we conducted a systematic review. Curious about the findings? Read the full article below.
Just published!📜📢
We are pleased to present our systematic review about the current evidence on antithrombotic drugs in migraine prevention and potential future applications.
headachejournal.onlinelibrar…
@mattfos89 @MicheleRomoli @ChiaraRosx @Simona_Sacco_ @RaffaeleOrnello
Just published!📜📢
We are pleased to present our systematic review about the current evidence on antithrombotic drugs in migraine prevention and potential future applications.
headachejournal.onlinelibrar…
@mattfos89 @MicheleRomoli @ChiaraRosx @Simona_Sacco_ @RaffaeleOrnello
Federico De Santis retweeted
Multi-center study provides new and encouraging real-world efficacy and safety data for rimegepant. doi.org/10.1186/s10194-024-0…
Federico De Santis retweeted
💊Short-term dual antiplatelet treatment may be safe and more effective than single antiplatelet treatment
🧑🤝🧑Study of 2,000+ participants
Read about it here👇
journals.sagepub.com/doi/ful…
@Simona_Sacco_ @mattfos89 @RaffaeleOrnello
@luciodanna2 @fededs00 @Eleonor32576320 @MicheleRomoli @ZiniAndrea @MlzZedde @giovmerl
Federico De Santis retweeted
Ensure to follow the new page of our research lab and join us in many collaborative research projects for 2025 🤩 important news coming soon… stay tuned!! ➡️@Simona_Sacco_ @RaffaeleOrnello @fededs00 @ChiaraRosx @univaq
Federico De Santis retweeted
#STROKE: The READAPT study shows that women with non-cardioembolic mild-to-moderate stroke or high-risk TIA treated with DAPT may have lower short-term risk of recurrent ischemic events than men. #AHAJournals #GoRedForWomen @GoRedForWomen ahajournals.org/doi/abs/10.1…
ALT Graphic abstract in Foschi and D’Anna et al.
Federico De Santis retweeted
💊Short-term dual antiplatelet treatment may be safe and more effective than single antiplatelet treatment
🧑🤝🧑Study of 2,000+ participants
Read about it here👇
journals.sagepub.com/doi/ful…
@Simona_Sacco_ @mattfos89 @RaffaeleOrnello
@luciodanna2 @fededs00 @Eleonor32576320 @MicheleRomoli @ZiniAndrea @MlzZedde @giovmerl
Federico De Santis retweeted
Just Accepted!
🗞️Real-world comparison of dual vs single antiplatelet treatment in patients with non-cardioembolic mild-to-moderate ischemic stroke: a propensity matched analysis
journals.sagepub.com/doi/abs…
@Simona_Sacco_ @mattfos89 @RaffaeleOrnello @luciodanna2 @fededs00 @Eleonor32576320 @MicheleRomoli @ZiniAndrea @MlzZedde
Federico De Santis retweeted
Advancing our approach to migraine prevention requires high-quality, academically led clinical trials.
doi.org/10.1177/033310242412…
@JCephalalgia @ihs_official
